Recursion Pharmaceuticals, Inc. (RXRX) - Risk-Adjusted Returns & Sharpe Ratio | pfolio
Recursion Pharmaceuticals, Inc. (RXRX): 1Y return -24.6%, Sharpe ratio -0.01, volatility 73.4%, max drawdown -58.2%. A Stock in the Equity asset class. Compare RXRX with other assets and invest through your own broker with pfolio.
Recursion Pharmaceuticals, Inc. (RXRX) Overview
- Type: Stock
- Asset Class: Equity
- Region: Americas
- Country: US (Developed)
- Currency: USD
RXRX Performance
- MTD
- Return: -2.9%, Sharpe: -0.06, Volatility: 141.8%, Max Drawdown: -17.4%
- YTD
- Return: -2.0%, Sharpe: 0.31, Volatility: 70.6%, Max Drawdown: -42.7%
- 1Y
- Return: -24.6%, Sharpe: -0.01, Volatility: 73.4%, Max Drawdown: -58.2%
- 5Y
- Return: -77.5%, Sharpe: 0.12, Volatility: 91.5%, Max Drawdown: -86.3%
Frequently Asked Questions
- What is Recursion Pharmaceuticals, Inc. (RXRX)?
- Recursion Pharmaceuticals, Inc. (RXRX) is a Stock in the Equity asset class. pfolio shows its cumulative return, volatility, Sharpe ratio, and max drawdown across MTD, YTD, 1Y, 5Y, 10Y, 20Y, and all-time periods.
- How does RXRX compare to other assets?
- You can compare RXRX with any other asset using pfolio's comparison tool, which ranks assets side-by-side by risk-adjusted returns.
- Can I invest in RXRX through pfolio?
- pfolio helps you build diversified portfolios that may include RXRX. You invest through your own broker — pfolio provides the analytics.